Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
INTEGRATION AND ANALYSIS OF BIOLOGICAL DATA FOR COMPUTATIONAL DRUG DISCOVERY
Download
Heval_Atas-Guvenilir_Tez.pdf
Date
2023-6-05
Author
Ataş Güvenilir, Heval
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
430
views
1374
downloads
Cite This
Drug discovery and development is a slow and costly process that comprises identifying bioactive compounds against biomolecular targets and evaluating their efficacy and safety. Computational drug/compound–target/protein interaction (DTI/CPI) prediction approaches have emerged as valuable tools to streamline this process and minimize expenses. In recent years, the integration of artificial intelligence (AI) based methods in DTI prediction has gained considerable attention, but challenges persist due to limitations in existing approaches and the complex nature of this biological problem. This thesis study aims to contribute to the effective utilization of AI in drug discovery by addressing current obstacles and developing innovative DTI prediction models. The main goal is to establish a reliable standard for designing robust and industry-applicable computational systems. The study is divided into three parts, each addressing a different aspect of the problem. In the first part, we performed a comprehensive benchmark for machine learning-based DTI prediction to achieve better data representations and more successful learning, and proposed high-quality bioactivity datasets for a fair and reliable comparison. In the second part, we utilized the knowledge graph (KG) data structure to leverage heterogeneous biological data for improved drug discovery, and constructed the KG module of our biological data integration system (CROssBAR) by incorporating essential relationships among multiple types of biomedical entities. In the last part, we proposed HetCPI, a systems-level CPI representation and prediction framework, which utilizes cutting-edge heterogeneous graph representation learning algorithms to extract hidden knowledge from multi-layered biomedical data, i.e., CROssBAR KGs, and demonstrates a considerable performance improvement in challenging scenarios. The outputs of this thesis study are expected to aid experimental and computational work in biomedical sciences, especially in drug discovery and repurposing.
Subject Keywords
machine/deep learning
,
bioactivity modeling
,
protein representation
,
biomedical knowledge graph
,
heterogeneous graph representation learning
URI
https://hdl.handle.net/11511/104453
Collections
Graduate School of Informatics, Thesis
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
H. Ataş Güvenilir, “INTEGRATION AND ANALYSIS OF BIOLOGICAL DATA FOR COMPUTATIONAL DRUG DISCOVERY,” Ph.D. - Doctoral Program, Middle East Technical University, 2023.